UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 269

Sortiert nach

Clinical implications of germline mutations in breast cancer: TP53

Breast cancer research and treatment, 2018-01, Vol.167 (2), p.417-423

2018

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis

British journal of cancer, 2022-04, Vol.126 (7), p.1067-1081

2022

Link zum Volltext

Verfügbarkeit prüfen

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors

Genetics in medicine, 2019-08, Vol.21 (8), p.1708-1718

2019

Link zum Volltext

Verfügbarkeit prüfen

Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP

Nature communications, 2019-05, Vol.10 (1), p.2373-2373, Article 2373

2019

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes

European journal of human genetics : EJHG, 2020-10, Vol.28 (10), p.1379-1386

2020

Link zum Volltext

Verfügbarkeit prüfen

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

The New England journal of medicine, 2015-06, Vol.372 (23), p.2243-2257

2015

Link zum Volltext

Verfügbarkeit prüfen

Hereditary breast cancer: new genetic developments, new therapeutic avenues

Human genetics, 2008-08, Vol.124 (1), p.31-42

2008

Link zum Volltext

Verfügbarkeit prüfen

CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants

Cancer epidemiology, biomarkers & prevention, 2021-03, Vol.30 (3), p.469-473

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical implications of germline mutations in breast cancer genes: RECQL

Breast cancer research and treatment, 2019-04, Vol.174 (3), p.553-560

2019

Link zum Volltext

Verfügbarkeit prüfen

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

The lancet oncology, 2011-09, Vol.12 (9), p.852-861

2011

Link zum Volltext

Verfügbarkeit prüfen

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

JNCI : Journal of the National Cancer Institute, 2013-06, Vol.105 (11), p.812-822

2013

Link zum Volltext

Verfügbarkeit prüfen

Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

Journal of clinical oncology, 2013-05, Vol.31 (14), p.1748-1757

2013

Link zum Volltext

Verfügbarkeit prüfen

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

European journal of human genetics : EJHG, 2020-10, Vol.28 (10), p.1387-1393

2020

Link zum Volltext

Verfügbarkeit prüfen

Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines

Clinical cancer research, 2020-08, Vol.26 (15), p.3908-3917

2020

Link zum Volltext

Verfügbarkeit prüfen

Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

Genetics in medicine, 2021-08, Vol.23 (8), p.1416-1423

2021

Link zum Volltext

Verfügbarkeit prüfen

A systematic review of predicted pathogenic PALB2 variants: an analysis of mutational overlap between epithelial cancers

Journal of human genetics, 2020-01, Vol.65 (2), p.199-205

2020

Link zum Volltext

Verfügbarkeit prüfen

Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis

Breast Cancer Research, 2023-02, Vol.25 (1), p.18-18, Article 18

2023

Link zum Volltext

Verfügbarkeit prüfen

The Prevalence of Clinical Features in Patients with Aarskog–Scott Syndrome and Assessment of Genotype-Phenotype Correlation: A Systematic Review

Genetics Research, 2021, Vol.2021, p.6652957-9

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

BMC cancer, 2007-07, Vol.7 (1), p.134-134, Article 134

2007

Link zum Volltext

Verfügbarkeit prüfen

Genotype, extrapyramidal features, and severity of variant ataxia‐telangiectasia

Annals of neurology, 2019-02, Vol.85 (2), p.170-180

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study

PloS one, 2020-03, Vol.15 (3), p.e0229999-e0229999

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(237)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Clinical implications of germline mutations in breast cancer: TP53

BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors

Personalized early detection and prevention of breast cancer: ENVISION consensus statement

Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP

Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Hereditary breast cancer: new genetic developments, new therapeutic avenues

CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants

Clinical implications of germline mutations in breast cancer genes: RECQL

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

Prostate Cancer Risks for Male BRCA1▪ and BRCA2 Mutation Carriers: A Prospective Cohort Study

The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome

Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines

Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

A systematic review of predicted pathogenic PALB2 variants: an analysis of mutational overlap between epithelial cancers

Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis

The Prevalence of Clinical Features in Patients with Aarskog–Scott Syndrome and Assessment of Genotype-Phenotype Correlation: A Systematic Review

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal

Genotype, extrapyramidal features, and severity of variant ataxia‐telangiectasia

Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study

Suchergebnisse filtern